This review will focus on the production and signalling pathways downstream LPI and the emerging evidence suggesting its role in metabolism, with specific interest in LPI, and its main receptor GPR55 involvement in metabolic diseases. This evidence concerns the gene GPR55 and Other metabolic disease.